This study measured part of the in-hive pesticide exposome by analyzing residues from live in-hive bees, stored pollen, and wax in migratory colonies over time and compared exposure to colony health.

Tools are provided to assess the health status of managed honeybee colonies by facilitating further harmonisation of data collection and reporting, design of field surveys across the European Union (EU) and analysis of data on bee health.

The mite Varroa destructor is an important honey bee parasite that causes substantial losses of honey bee colonies worldwide.

Here we present results of a three-year study to determine the fate of imidacloprid residues in hive matrices and to assess chronic sublethal effects on whole honey bee colonies fed supplemental pollen diet containing imidacloprid at 5, 20 and 100 µg/kg over multiple brood cycles.

American Foulbrood (AFB) is caused by a Gram-positive, rod shaped, spore-forming bacterium called Paenibacillus larvae.

Chalkbrood is one of the most common and widely recognised fungal diseases that affects honeybee brood, the causative agent of which is Ascosphaera apis. Currently, there are no approved treatments for the management of Chalkbrood infection in beekeeping operations. Anecdotal evidence from beekeepers suggests that use of the feed supplement HiveAlive may cause a reduction in Chalkbrood infection.

Palynology is considered one of the most important tools in the study of plantbee interactions. Among the various pollinating agents that exist in nature, bees occupy a prominent place because they live in society, but also in a solitary way, and have characteristics that favor pollination.

The U.S. Department of Agriculture (USDA) prohibits discrimination against its customers, employees, and applicants for employment

Automatic tracking and identification of individuals has the potential to revolutionize the study of insects, especially social insects, by opening up options for questions which could not be asked before.

We review the effects of propolis, an old remedy with proven antiviral properties, as a possible low-cost inhibitor of SARS-CoV-2 in the oropharyngeal niche, prophylaxis, or adjuvant therapy.